Analyst Ratings for Lexeo Therapeutics (LXEO)
LXEO Rating Summary
LXEO Price Target Summary
- Highest: $30.00 (Guggenheim)
- Lowest: $9.00 (Leerink Partners)
- Average: $18.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$18.71 (+173.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$18.71 (+173.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/18/2025 | Raymond James | Christopher Raymond | New Coverage | Strong Buy (N/A) |
25.00 (N/A) |
9.73 (6.85) |
-29.6% | Details |
| 11/20/2025 | Cantor Fitzgerald » Updated 1/13/2026 |
Kristen Kluska | New Coverage | Overweight (N/A) |
19.00 (N/A) |
9.09 (6.85) |
-24.64% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
